Predictors of Vertigo After Endolymphatic Sac Surgery ID'd in Meniere Disease
Medically reviewed by Drugs.com. Last updated on Nov 1, 2023.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Nov. 1, 2023 -- Audiogram type and pure-tone threshold average can predict vertigo after endolymphatic sac decompression (ESD) in Meniere disease (MD), according to a study published online Sept. 25 in the European Archives in Oto-Rhino-Laryngology.
Yiling Li, from the Air Force Medical Center in Beijing, and colleagues conducted a retrospective cohort study involving 56 patients with unilateral MD who underwent ESD surgery. Optimal modeling variables were selected using a stepwise regression method, and a logistic regression model was established with the outcome of vertigo after ESD.
The researchers found that the optimal modeling variables were the audiogram type and pure-tone threshold average of the patient's speech frequency. Based on these two variables, the prediction model exhibited good discrimination (area under the receiver operating characteristic curve, 0.72) and acceptable calibration (Brier score, 0.21).
"Using the abovementioned predictive model, individualized treatment plans can be prepared by evaluating preoperative data and unnecessary destructive surgeries selected due to the fear of failed vertigo control could be avoided," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Triple Semicircular Canal Occlusion + Endolymphatic Sac Decompression Alleviates Vertigo
WEDNESDAY, June 5, 2024 -- Triple semicircular canal occlusion combined with endolymphatic sac decompression (ESD) may be an effective treatment option for managing frequent...
ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma
WEDNESDAY, June 5, 2024 -- Neoadjuvant ipilimumab plus nivolumab followed by surgery results in longer event-free survival than surgery followed by adjuvant nivolumab among...
Cochlear Implants Aid Meniere Disease Outcomes
TUESDAY, June 4, 2024 -- Cochlear implantation (CI) positively impacts hearing, vertigo, tinnitus, and quality of life in patients with Meniere disease (MD), according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.